Skip to content
FDA drug shortage status

Is Tadalafil Tablet (Adcirca) in shortage?

Tadalafil Tablet is listed by FDA as being discontinued by at least one maker (updated Nov 5, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Adcirca, Tablet, 20 mg (NDC 66302-467-60)
    Eli Lilly and Co.Being discontinuedUpdated Nov 5, 2026Discontinued Nov 5, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 844-864-8437 or 800-545-5979

FDA recalls of Tadalafil

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Tadalafil Tablet:

Tadalafil Tablet shortage questions

Is Tadalafil Tablet (Adcirca) in shortage?

Tadalafil Tablet is listed by FDA as being discontinued by at least one maker (updated Nov 5, 2026).

What should I do if I can’t get Tadalafil Tablet?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.